These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 10399995
21. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Beckwith C, Munger MA. Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800 [Abstract] [Full Text] [Related]
22. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [Abstract] [Full Text] [Related]
23. Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction. Weber S, Vaur L, Ounnoughene Z, Schwob J, Dubroca I, Normand J, Etienne S, Charbonnier B. Am Heart J; 2002 Feb; 143(2):313-8. PubMed ID: 11835037 [Abstract] [Full Text] [Related]
24. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL, PEACE Trial Investigators. N Engl J Med; 2004 Nov 11; 351(20):2058-68. PubMed ID: 15531767 [Abstract] [Full Text] [Related]
25. Efficacy and safety of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia. Balling L, Kober L, Schou M, Torp-Pedersen C, Gustafsson F. J Card Fail; 2013 Nov 11; 19(11):725-30. PubMed ID: 24263115 [Abstract] [Full Text] [Related]
29. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Barron HV, Michaels AD, Maynard C, Every NR. J Am Coll Cardiol; 1998 Aug 11; 32(2):360-7. PubMed ID: 9708461 [Abstract] [Full Text] [Related]
30. Comparison of effectiveness of angiotensin-converting enzyme inhibitors after acute myocardial infarction in diabetic versus nondiabetic patients. Gottlieb S, Leor J, Shotan A, Harpaz D, Boyko V, Rott D, Mandelzweig L, Behar S, Working Group on Intensive Cardiac Care, Israel Heart Society. Am J Cardiol; 2003 Nov 01; 92(9):1020-5. PubMed ID: 14583350 [Abstract] [Full Text] [Related]
38. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. Frances CD, Noguchi H, Massie BM, Browner WS, McClellan M. Arch Intern Med; 2000 Sep 25; 160(17):2645-50. PubMed ID: 10999979 [Abstract] [Full Text] [Related]
40. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials. Saha SA, Molnar J, Arora RR. Diabetes Obes Metab; 2008 Jan 25; 10(1):41-52. PubMed ID: 18095949 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]